Literature DB >> 12670910

Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Charles R Holst1, Gerard J Nuovo, Manel Esteller, Karen Chew, Stephen B Baylin, James G Herman, Thea D Tlsty.   

Abstract

Cultures of human mammary epithelial cells (HMECs) contain a subpopulation of variant cells with the capacity to propagate beyond an in vitro proliferation barrier. These variant HMECs, which contain hypermethylated and silenced p16(INK4a) (p16) promoters, eventually accumulate multiple chromosomal changes, many of which are similar to those detected in premalignant and malignant lesions of breast cancer. To determine the origin of these variant HMECs in culture, we used Luria-Delbrück fluctuation analysis and found that variant HMECs exist within the population before the proliferation barrier, thereby raising the possibility that variant HMECs exist in vivo before cultivation. To test this hypothesis, we examined mammary tissue from normal women for evidence of p16 promoter hypermethylation. Here we show that epithelial cells with methylation of p16 promoter sequences occur in focal patches of histologically normal mammary tissue of a substantial fraction of healthy, cancer-free women.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  2003        PMID: 12670910

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

Review 1.  Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Authors:  Nuria Rodríguez Salas; Enrique González González; Carlos Gamallo Amat
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

Review 3.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

4.  Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.

Authors:  Maria A Hahn; Torsten Hahn; Dong-Hyun Lee; R Steven Esworthy; Byung-Wook Kim; Arthur D Riggs; Fong-Fong Chu; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Epithelial cell translocation: new insights into mechanisms of tumor initiation.

Authors:  Cheuk T Leung
Journal:  Bioessays       Date:  2012-12-19       Impact factor: 4.345

6.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

7.  Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India.

Authors:  Mohammad Raish; Varinderpal S Dhillon; Arif Ahmad; Mushtaq Ahmad Ansari; Shahid Mudassar; Mohammad Shahid; Vineeta Batra; Pawan Gupta; Bhudev Chandra Das; Nk Shukla; Syed Akhtar Husain
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 8.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies.

Authors:  Rituparna Mukhopadhyay; Sylvain V Costes; Alexey V Bazarov; William C Hines; Mary Helen Barcellos-Hoff; Paul Yaswen
Journal:  Breast Cancer Res       Date:  2010-02-10       Impact factor: 6.466

10.  Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection?

Authors:  Yasser Riazalhosseini; Jörg D Hoheisel
Journal:  Genome Biol       Date:  2008-11-26       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.